Literature DB >> 23780707

Clinical and pathological characteristics of incidental and nonincidental papillary thyroid microcarcinoma in 339 patients.

Ioannis Vasileiadis1, Theodore Karatzas, Dimitrios Vasileiadis, Stylianos Kapetanakis, Georgios Charitoudis, Efthimios Karakostas, Gregory Kouraklis.   

Abstract

BACKGROUND: We analyzed the incidence and the clinicopathological characteristics of papillary thyroid microcarcinoma (PTMC) in a high prevalence region of goiter with the purpose to investigate differences between incidental and nonincidental PTMC.
METHODS: A total of 2236 patients who underwent total thyroidectomy from 2001 to 2009 were reviewed retrospectively. Papillary carcinoma was diagnosed in 583 patients. Of these, 339 patients with PTMC were included in the study. Clinicopathological features were evaluated by univariate and multivariate analysis.
RESULTS: The prevalence of incidental PTMC was 12% of all patients who underwent surgery for thyroid disease. Univariate analysis showed that bilaterality (p = .001), autoimmune thyroid disease (p = .049), size of tumor >5 mm (p < .001), multifocality (p < .001), lymph node metastasis (p < .001), and capsule invasion (p < .001) were significantly associated with nonincidental PTMC. The incidence of lymph node metastasis in incidental PTMC was 5% versus 33% in nonincidental, suggesting that the biological behavior may be different in the 2 categories.
CONCLUSION: Our results indicate that a high rate of PTMC presented 1 or more risk factors including multifocality, bilaterality, capsule invasion, and lymph node metastasis. Therefore, we suggest total thyroidectomy followed by adequate exploration of the central neck compartment for possible nodal involvement and resection as a safe therapeutic approach.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  clinicopathological characteristics; incidental; nonincidental; papillary thyroid microcarcinoma; surgical treatment

Mesh:

Year:  2013        PMID: 23780707     DOI: 10.1002/hed.23333

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  11 in total

1.  Papillary Thyroid Microcarcinoma: Reclassification to Non-Invasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP): a Retrospective Clinicopathologic Study.

Authors:  Khurram Shafique; Virginia A LiVolsi; Kathleen Montone; Zubair W Baloch
Journal:  Endocr Pathol       Date:  2018-12       Impact factor: 3.943

2.  Should small papillary thyroid cancer be observed? A population-based study.

Authors:  Naris Nilubol; Electron Kebebew
Journal:  Cancer       Date:  2014-11-25       Impact factor: 6.860

3.  Incidental and non-incidental thyroid microcarcinoma.

Authors:  Krzysztof Kaliszewski; Beata Wojtczak; Marta Strutyńska-Karpińska; Tadeusz Łukieńczuk; Zdzisław Forkasiewicz; Paweł Domosławski
Journal:  Oncol Lett       Date:  2016-05-30       Impact factor: 2.967

4.  To Identify Predictors of Central Lymph Node Metastasis in Patients with Clinically Node-Negative Conventional Papillary Thyroid Carcinoma.

Authors:  Jiru Yuan; Gang Zhao; Jialin Du; Xiaoyi Chen; Xiaodong Lin; Zhengbo Chen; Zeyu Wu
Journal:  Int J Endocrinol       Date:  2016-12-15       Impact factor: 3.257

5.  Clinical analysis of cervical lymph node metastasis risk factors in patients with papillary thyroid microcarcinoma.

Authors:  Y Luo; Y Zhao; K Chen; J Shen; J Shi; S Lu; J Lei; Z Li; D Luo
Journal:  J Endocrinol Invest       Date:  2018-06-06       Impact factor: 4.256

6.  Clinical Analysis of Cervical Lymph Node Metastasis Risk Factors and the Feasibility of Prophylactic Central Lymph Node Dissection in Papillary Thyroid Carcinoma.

Authors:  Yifan Chen; Shuo Chen; Xiaoying Lin; Xiangqing Huang; Xiaofang Yu; Juying Chen
Journal:  Int J Endocrinol       Date:  2021-01-31       Impact factor: 3.257

7.  Incidental Papillary Thyroid Microcarcinoma in an Endemic Goiter Area.

Authors:  Emin Gürleyik; Gunay Gurleyik; Banu Karapolat; Ufuk Onsal
Journal:  J Thyroid Res       Date:  2016-02-02

8.  Accessing the influence of 99mTc-Sesta-MIBI-positive thyroid nodules on preoperative localisation studies in patients with primary hyperparathyroidism.

Authors:  Lindsay Hargitai; Maria Schefner; Tatjana Traub-Weidinger; Alexander Haug; Melisa Arikan; Christian Scheuba; Philipp Riss
Journal:  Langenbecks Arch Surg       Date:  2022-01-21       Impact factor: 2.895

9.  Risk of Thyroid Cancer Associated with Use of Liraglutide and Other Antidiabetic Drugs in a US Commercially Insured Population.

Authors:  Donnie Funch; Kathleen Mortimer; Najat J Ziyadeh; John D Seeger; Li Zhou; Eva Ng; Douglas Ross; Atheline Major-Pedersen; Heidrun Bosch-Traberg; Helge Gydesen; David D Dore
Journal:  Diabetes Metab Syndr Obes       Date:  2021-06-10       Impact factor: 3.168

10.  Young age increases the risk of lymph node positivity in papillary thyroid cancer patients: a SEER data-based study.

Authors:  Jing Wang; Jianjun Liu; Huayuan Pan; Chenghao Jiang; Song Liu; Zhengzhi Zhu; Jing Fang; Xucai Zheng; Shikai Hong; Shengying Wang
Journal:  Cancer Manag Res       Date:  2018-09-25       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.